EHC Encompass Health Corp

Price (delayed)

$101.28

Market cap

$10.2B

P/E Ratio

22.36

Dividend/share

$0.66

EPS

$4.53

Enterprise value

$12.79B

Encompass Health Corporation , based in Birmingham, Alabama, is one of the United States' largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services in 36 states ...

Highlights
Encompass Health's net income has increased by 29% YoY and by 8% from the previous quarter
Encompass Health's EPS has increased by 29% YoY and by 8% from the previous quarter
Encompass Health's quick ratio has decreased by 21% YoY
The P/E is 8% above the 5-year quarterly average of 20.8 and 2.6% above the last 4 quarters average of 21.8

Key stats

What are the main financial stats of EHC
Market
Shares outstanding
100.71M
Market cap
$10.2B
Enterprise value
$12.79B
Valuations
Price to earnings (P/E)
22.36
Price to book (P/B)
4.94
Price to sales (P/S)
1.88
EV/EBIT
14.47
EV/EBITDA
10.8
EV/Sales
2.38
Earnings
Revenue
$5.37B
Gross profit
$1.37B
Operating income
$864.5M
Net income
$596.6M
EBIT
$884.2M
EBITDA
$1.18B
Free cash flow
$360.3M
Per share
EPS
$4.53
EPS diluted
$4.46
Free cash flow per share
$3.61
Book value per share
$20.52
Revenue per share
$53.79
TBVPS
$49.58
Balance sheet
Total assets
$6.53B
Total liabilities
$3.69B
Debt
$2.71B
Equity
$2.07B
Working capital
$45.9M
Liquidity
Debt to equity
1.31
Current ratio
1.05
Quick ratio
0.86
Net debt/EBITDA
2.19
Margins
EBITDA margin
22%
Gross margin
25.6%
Net margin
11.1%
Operating margin
16.1%
Efficiency
Return on assets
9.3%
Return on equity
31.4%
Return on invested capital
13.1%
Return on capital employed
15.5%
Return on sales
16.5%
Dividend
Dividend yield
0.65%
DPS
$0.66
Payout ratio
14.6%

EHC stock price

How has the Encompass Health stock price performed over time
Intraday
0%
1 week
0.41%
1 month
1.14%
1 year
21.69%
YTD
9.67%
QTD
0%

Financial performance

How have Encompass Health's revenue and profit performed over time
Revenue
$5.37B
Gross profit
$1.37B
Operating income
$864.5M
Net income
$596.6M
Gross margin
25.6%
Net margin
11.1%
Encompass Health's net income has increased by 29% YoY and by 8% from the previous quarter
Encompass Health's operating income has increased by 18% YoY and by 5% from the previous quarter
The net margin has grown by 16% YoY and by 4.7% from the previous quarter
EHC's gross profit is up by 14% YoY and by 3.9% from the previous quarter

Growth

What is Encompass Health's growth rate over time

Valuation

What is Encompass Health stock price valuation
P/E
22.36
P/B
4.94
P/S
1.88
EV/EBIT
14.47
EV/EBITDA
10.8
EV/Sales
2.38
Encompass Health's EPS has increased by 29% YoY and by 8% from the previous quarter
The P/E is 8% above the 5-year quarterly average of 20.8 and 2.6% above the last 4 quarters average of 21.8
The company's equity rose by 25% YoY and by 5% QoQ
EHC's price to book (P/B) is 15% higher than its 5-year quarterly average of 4.3 and 5% higher than its last 4 quarters average of 4.7
EHC's P/S is 18% above its 5-year quarterly average of 1.6 and 11% above its last 4 quarters average of 1.7
Encompass Health's revenue has increased by 12% YoY and by 3% QoQ

Efficiency

How efficient is Encompass Health business performance
Encompass Health's return on assets has increased by 19% YoY and by 6% QoQ
The ROIC has grown by 16% YoY and by 4.8% from the previous quarter
Encompass Health's ROS has increased by 7% YoY and by 2.5% from the previous quarter
Encompass Health's ROE has increased by 3% YoY and by 2.3% from the previous quarter

Dividends

What is EHC's dividend history
DPS
$0.66
Dividend yield
0.65%
Payout ratio
14.6%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Encompass Health financials performed over time
The total assets is 77% greater than the total liabilities
Encompass Health's quick ratio has decreased by 21% YoY
EHC's current ratio is down by 18% year-on-year
The debt is 31% more than the equity
Encompass Health's debt to equity has decreased by 26% YoY and by 8% from the previous quarter
The company's equity rose by 25% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.